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Abstract
To elucidate the mechanisms involved in early events in Chlamydia trachomatis infection, we conducted a large scale
unbiased RNA interference screen in Drosophila melanogaster S2 cells. This allowed identification of candidate host factors
in a simple non-redundant, genetically tractable system. From a library of 7,216 double stranded RNAs (dsRNA), we
identified,226 host genes, including two tyrosine kinases, Abelson (Abl) kinase and PDGF- and VEGF-receptor related (Pvr),
a homolog of the Platelet-derived growth factor receptor (PDGFR). We further examined the role of these two kinases in C.
trachomatis binding and internalization into mammalian cells. Both kinases are phosphorylated upon infection and
recruited to the site of bacterial attachment, but their roles in the infectious process are distinct. We provide evidence that
PDGFRb may function as a receptor, as inhibition of PDGFRb by RNA interference or by PDGFRb neutralizing antibodies
significantly reduces bacterial binding, whereas depletion of Abl kinase has no effect on binding. Bacterial internalization
can occur through activation of PDGFRb or through independent activation of Abl kinase, culminating in phosphorylation of
the Rac guanine nucleotide exchange factor (GEF), Vav2, and two actin nucleators, WAVE2 and Cortactin. Finally, we show
that TARP, a bacterial type III secreted actin nucleator implicated in entry, is a target of Abl kinase. Together, our results
demonstrate that PDGFRb and Abl kinases function redundantly to promote efficient uptake of this obligate intracellular
parasite.
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Introduction
Chlamydia species cause a wide range of diseases in humans,
including sexually transmitted, ocular, and respiratory tract
infections (reviewed in [1]). Chronic Chlamydia infections can
result in female infertility, blindness, and possibly atherosclerosis
[2]. Despite the broad spectrum of chlamydial diseases, all Chlamydia
species share a common strategy that allows this obligate
intracellular parasite to survive within the host cell [3]. Infection
is initiated by binding and internalization of the extracellular
infectious form, the elementary body (EB), which is small (0.3 mm)
and metabolically inactive, into target host cells. EBs enter into a
membrane-bound compartment, which quickly dissociates from
the endocytic pathway and avoids phagolysosomal fusion [4].
Within a few hours, EBs differentiate into larger (1 mm) reticulate
bodies (RBs) that represent the metabolically active, replicative
form. The RBs replicate by binary fission within the enlarging
inclusion over a 48–72 hour time period, and then undergo a
second differentiation process back to infectious EBs, which are
released from host cells.
The mechanisms involved in binding and uptake, including the
identity of the bacterial ligand and the host cell receptor, are
incompletely defined. The fact that chlamydiae can productively
infect most cultured cells suggests that the receptor(s) may be
widespread, that chlamydiae utilize multiple means of entry, and/
or that these organisms inject their own receptor, possibly by type
III secretion. For some species and serovars, including the more
invasive Lymphogranuloma Venereum (LGV) serovar L2, he-
paran sulfate has been suggested to act as a bridging molecule for a
relatively weak and reversible interaction [5–8] that is followed by
a stronger, more specific binding to an unidentified secondary
receptor [9,10]. Internalization of Chlamydia is accompanied by
induction of microvilli-like structures over a large portion of the
host cell in a process that is dependent upon actin polymerization
[11]. Indeed, actin reorganization is observed at the sites of
Chlamydia entry [12,13], and inhibition of actin polymerization
blocks entry [11]. The Rho family GTPase, Rac, is activated upon
infection and is required for C. trachomatis entry while both Rac and
Cdc42 appear to be required for C. caviae entry [12,13].
The molecules involved in Rac activation and in subsequent
actin rearrangements necessary for C. trachomatis entry are
unknown. Tyrosine phosphorylation of several unidentified
proteins has been observed early in infection, and tyrosine
phosphorylated proteins have been shown to accumulate around
EBs at the entry site for several Chlamydia species [14–18]. In the
case of C. trachomatis, Translocated actin recruiting phosphoprotein
(TARP), a type III secreted bacterial protein, is rapidly tyrosine
phosphorylated upon infection and is associated with actin
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recruitment [17]. While TARP is encoded in all Chlamydia species
examined thus far, only C. trachomatis TARP orthologs possess
several tyrosine-rich tandem repeats of approximately 50 amino
acids in length [17]. Studies utilizing ectopic expression of C.
trachomatis TARP in mammalian cells reveal that phosphorylation
occurs within this repeat region in the N-terminus and that the C-
terminal domain of TARP is essential for actin recruitment [16].
In addition, a recent report reveals that TARP can nucleate actin
in vitro [19]. Based on these observations, TARP has been
proposed to play a role in bacterial internalization by modulating
cytoskeletal reorganization at the site of entry. The tyrosine kinase
that phosphorylates TARP has not been identified, however it is
believed to be of host origin since TARP is phosphorylated upon
transfection in mammalian cells or when delivered into host cells
by the Yersinia type III secretion system [16,17].
The study of Chlamydia pathogenesis has been hampered by the
inability to carry out traditional genetics. Genetically tractable
organisms, including Drosophila melanogaster, provide an attractive
alternate avenue of exploration. The ease and availability of using
RNA interference (RNAi) to inactivate gene expression and the
lack of redundancy in the genome compared to mammals affords
the opportunity to uncover complicated or redundant signaling
pathways that might otherwise be overlooked. In this paper, we
describe a high throughput RNAi based screen to identify host
factors required for early steps in C. trachomatis infection. We have
focused on a subset of candidates known to be important for Rac-
dependent cytoskeletal rearrangements, including PDGF- and
VEGF-receptor related (Pvr; a homolog of the Platelet-derived
growth factor receptor (PDGFR)), Abelson (Abl) kinase, Vav,
WAVE, and Cortactin [20–26]. Using genetic, chemical, and
biochemical approaches, we examined the role of these signaling
molecules in mammalian infections. We demonstrate that
PDGFRb functions as a receptor for C. trachomatis. Once bound,
bacterial internalization can occur either through activation of
PDGFRb or through independent activation of Abl kinase.
Activation of these kinases leads to phosphorylation of the Rac
guanine nucleotide exchange factor (GEF) Vav2, and several actin
nucleators, including WAVE2, Cortactin, and TARP, that likely
promote efficient uptake of this obligate intracellular parasite.
Results
RNAi screen to identify host proteins required for C.
trachomatis infection
We have previously shown that C. trachomatis infection of D.
melanogaster S2 cells recapitulates early steps in the interaction of C.
trachomatis with mammalian cells, including binding, entry, and
escape from phagolysomal fusion [27]. Later steps, such as
bacterial replication or release from S2 cells do not occur because
of the very limited replication of C. trachomatis below 30uC and the
inability of S2 cells to survive above 30uC [27]. Here, we used a
library of 7,216 double stranded RNAs (dsRNA) representing most
of the phylogenetically conserved genes of D. melanogaster [28] to
perform an RNAi screen in S2 cells to identify host gene products
important for early stages of C. trachomatis infection, up to and
including inclusion formation. For screening, S2 cells were
incubated with each individual dsRNA for 4 days and then
infected with C. trachomatis strain L2 for 48 hours. Cells were then
replated onto 96 well glass bottom plates, fixed, and stained with a
Fluorescein isothiocyanate (FITC)-conjugated antibody that rec-
ognizes the Chlamydia major outer membrane protein (MOMP) to
visualize inclusions, and counterstained with Evan’s blue to
visualize cells. We performed a visual screen to identify changes
in the efficiency of inclusion formation, alterations in inclusion
morphology, and decreased host cell viability.
The primary screen identified 862 putative host genes required
for early steps in C. trachomatis infections. A large number of these
genes appeared to be involved in general host cell processes, such
as gene expression and protein degradation. Indeed, many of these
genes have been identified in other screens for microbial uptake
[29,30]. Since depletion of many of these genes would be predicted
to have pleiotropic affects that would likely indirectly affect C.
trachomatis infection, these genes were not further analyzed.
We retested 360 dsRNAs and identified approximately 226 host
gene products that likely participate in distinct stages of the C.
trachomatis developmental cycle, including binding, entry, traffick-
ing, inclusion formation, inhibition of phagolysosomal fusion,
survival, or modulation of host signaling pathways. The gene
products that affected C. trachomatis inclusion formation identified
in the screen can be divided into the following categories: Cell
Cycle, Cytoskeleton, Electron Transport, Heparan Sulfate Me-
tabolism, Immune Defense, Ion Transport, Lipid Metabolism,
Protein Transport, Signal Transduction, Transcription Regulaton,
Translation, and Vesicle Transport (Figure 1 and Table S1). In
many cases, we identified multiple subunits of known protein
complexes or multiple components of known biochemical
pathways. Some of the proteins have been previously implicated
in C. trachomatis infection, further supporting their role in C.
trachomatis infection and also validating our approach. These
included (1) Lace, the Drosophila homolog of Spt-1 (sphingosine
palmitoyl transferase), the rate limiting enzyme in sphingolipid
biosynthesis, which is necessary for intracellular survival [31]; (2)
Rac, which is required for C. trachomatis internalization [12]; (3)
enzymes involved in heparan sulfate metabolism, which is
consistent with the known requirement for heparan sulfate in
binding [5–8]; and (4) several Rabs and Rab-related proteins,
which have been shown to localize to the vacuole [32–35]. The
identification of factors known to be involved in C. trachomatis
infection gave us confidence that the novel candidates could be
playing a previously unrecognized role in infection by C.
trachomatis.
We were particularly interested in two tyrosine kinases, PDGFR
and Abl kinase, because (1) several components of the signal
transduction pathways involving PDGFR and Abl kinase [20–
Author Summary
Chlamydia trachomatis infections are a worldwide prob-
lem; they are the leading cause of preventable blindness in
developing nations and the most common cause of
sexually transmitted disease in the Western world. Binding
and entry into host cells are critical steps to the
pathogenesis of this obligate intracellular parasite; how-
ever little is known regarding the mechanism of these
processes. In this work, we describe a large scale RNA
interference screen to identify host factors essential for
early steps in C. trachomatis infection. We discover that the
Platelet Derived Growth Factor Receptor b (PDGFRb) can
function as a receptor for C. trachomatis, and that
activation of both PDGFRb and Abl kinase signaling
pathways by C. trachomatis leads to phosphorylation of a
Rac guanine nucleotide exchange factor, Vav2, and several
actin nucleators, including WAVE2, Cortactin, and TARP, a
Chlamydia type III secreted effector. Our work suggests a
model of redundant activation of PDGFRb and Abl kinase
upon C. trachomatis binding that culminates in cytoskel-
etal rearrangements that modulate efficient uptake of this
obligate intracellular parasite.
Signaling during Chlamydia Entry
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26,36,37] were identified in our screen, including Abi, WAVE,
Nap, Crk, Vav, Arp2/3, and Cortactin, (2) both kinases are
involved in Rac-dependent cytoskeletal rearrangements, processes
known to be required for C. trachomatis entry [12], and because (3)
C. trachomatis entry is associated with accumulation of tyrosine
phosphorylated proteins at the site of entry, including the
bacterially-encoded TARP. We further examined the role of these
kinases in C. trachomatis infection of mammalian cells.
Platelet-derived growth factor receptor b is activated
upon infection and recruited to the site of EB entry
Members of the PDGF receptor family are receptor tyrosine
kinases and consist of two receptor forms, PDGFRa and
PDGFRb, that form homo or heterodimers upon binding of the
growth factor receptor ligand, PDGF [38]. These receptors are
important for cell proliferation and cell migration [38]. Receptor
dimerization upon ligand binding stimulates the intrinsic tyrosine
kinase activity of the receptors, leading to receptor autopho-
sphorylation as well as recruitment and tyrosine phosphorylation
of various downstream effectors [38]. To determine whether
PDGFRb is activated upon infection, HeLa cells were infected
with L2 for 1 hour, and lysates were immunoprecipitated with
anti-PDGFRb antibodies followed by immunoblotting with the
anti-phosphotyrosine antibody, 4G10. As a positive control for
receptor phosphorylation and activation, a parallel set of cells was
treated with PDGF-BB. As shown in Figure 2A, PDGFRb was
phosphorylated upon infection with L2. This phosphorylation was
blocked when cells were incubated prior to and during infection
with two chemically distinct inhibitors of PDGFR activity, STI571
[39,40], (Figure 2A), or AG1295 [41] (data not shown). Whereas
STI571 also inhibits Abl family kinases, AG1295 is specific for
PDGFR. Pretreatment of EBs with STI571 or AG1295 did not
affect their viability, as evidenced by their ability to form normal
inclusions in HeLa cells (data not shown). L2 did not induce
phosphorylation of Epidermal Growth Factor Receptor (EGFR;
Figure 2B), suggesting there is specificity for PDGFRb.
We confirmed these results by examining whether catalytically
activated PDGFRb was recruited to EBs during entry using
immunofluorescence microscopy (IF) with an antibody that
recognizes phosphorylated (activated) PDGFRb. As shown in
Figure 2C, phosphorylated PDGFRb was recruited to most but
not all bound EBs; this phosphorylation was inhibited by STI571
and AG1295 (Figure 2C). We could not detect recruitment of
phosphorylated EGFR to EBs (data not shown).
PDGFRb contributes to C. trachomatis L2 binding
Since PDGFR is a transmembrane receptor, we investigated the
possibility that PDGFRb could serve as a receptor or coreceptor
for C. trachomatis. Using RNAi, we depleted HeLa cells of PDGFRb
EGFR, or Abl kinase for 48 hrs. Cells were then infected with C.
trachomatis for 1 hour and analyzed by inside out staining as
described in Materials and Methods. The efficiency of protein
depletion was determined by Western blot analysis (Figure 3B).
We first determined the total number of cell-associated bacteria
(which includes internalized and surface-associated bacteria) for
each treatment, and expressed this number as percent of cell-
associated bacteria normalized to the control small interfering
RNA (siRNA) sample. PDGFRb depletion resulted in a 50%
reduction in cell-associated bacteria, whereas depletion of EGFR
or Abl kinase had no effect (Figure 3A). We then assessed
internalization efficiency in the same cells by determining the
percentage of internalized EBs/total cell-associated EBs. PDGFRb
EGFR, and Abl kinase depletion showed no effect on internali-
zation efficiency (Figure 3A). Together, these data show that
depletion of PDGFRb diminishes host-cell association but not
internalization efficiency of bacteria, suggesting that PDGFRb is
important for binding to host cells. Its role in internalization will be
discussed later.
We further confirmed a role for PDGFRb in binding by using a
neutralizing antibody to PDGFRb. A dose-dependent decrease in
cell-associated bacteria was observed when cells were preincubated
with a PDGFRb neutralizing antibody, whereas an EGFR
neutralizing antibody had no significant effect (Figure 3C). Both
PDGFRb and EGFR neutralizing antibodies showed no effect on
the internalization efficiency of C. trachomatis into cells (data not
shown). These results indicate that PDGFRb mediates binding of
C. trachomatis L2 to host cells. However, as none of the PDGFRb-
directed treatments completely abolished host-cell association,
other cellular receptors may also contribute to C. trachomatis
binding.
Figure 1. Categories of host genes identified in RNAi screen. Number of genes in each class is indicated.
doi:10.1371/journal.ppat.1000021.g001
Signaling during Chlamydia Entry
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Abl kinase is activated and recruited to EBs
The Abl kinase family, which includes Abl and Arg, are
nonreceptor tyrosine kinases comprised of a Src homology 2 (SH2)
domain, a Src homology 3 (SH3) domain, an activation domain
that can undergo autophosphorylation, and actin binding domains
(reviewed in [18]). Abl kinases are involved in many important
mammalian processes, including cell cycle regulation, apoptosis,
response to DNA damage, and Rac-dependent cytoskeletal
dynamics [18,42–45]. To determine whether Abl kinase is
activated upon infection, HeLa cells infected with C. trachomatis
for 1 hour were fixed and stained with an antibody that specifically
recognizes Abl when it is phosphorylated on Y412 in the activation
loop domain; this phosphorylation is an indicator of its catalytic
activation [46–48]. Abl kinase (Figure 4, panels A–D) and the
closely related Arg kinase (data not shown) were activated and
recruited to most cell-associated EBs. Bacterial infection also
resulted in a significant increase in the phosphorylation of CrkII, a
substrate of Abl kinase (Figure S4), further supporting that Abl
kinase was activated upon EB binding. Moreover, phosphorylated
CrkII was recruited to EBs in infected HeLa and wild type 3T3
cells (data not shown), whereas no recruitment of phosphorylated
CrkII was observed in 3T3 cells derived from mice lacking both
Abl and Arg kinase (data not shown) [49]. Pretreatment of cells
with STI571 blocked C. trachomatis-induced Abl phosphorylation,
without affecting recruitment of Abl kinase to EBs (Figure 4,
panels E–H and Figure S1; 89% reduction; ***p,0.001). We
could not detect changes in Abl kinase phosphorylation by
immunoblot analysis of infected lysates using anti-Y412 antibody,
presumably because Abl activation occurs locally at the site of EB
entry and represents only a small percentage of the total Abl in the
cell. In addition, activated Abl has been shown to undergo rapid
ubiquitin-mediated degradation by the proteasome [50,51].
It has been reported that Abl activation occurs by both
PDGFR-dependent and independent pathways [44]. We exam-
ined whether C. trachomatis stimulation of Abl kinase activty was
dependent on PDGFR activation. Whereas STI571 inhibited C.
trachomatis-induced recruitment of phosphorylated Abl kinase,
AG1295, a specific inhibitor of PDGFR, had no effect (Figure 4,
panels I–L, and Figure S1). Together, these results indicate that
while PDGFR can function as a receptor for C. trachomatis and is
activated by bacterial binding, activation of Abl kinase by C.
trachomatis can occur independently of PDGFR activation.
Abl kinases are required for tyrosine phosphorylation of
proteins associated with EBs at the site of entry
Several groups have reported that EB entry is associated with
recruitment of tyrosine phosphorylated proteins [15,16,52,53]. We
used pharmacologic and genetic approaches to determine whether
PDGFR and Abl family kinases contributed to the tyrosine
phosphorylation events associated with EBs during entry.
Pretreatment of C. trachomatis-infected HeLa cells with STI571
diminished association of phospho-tyrosine-containing proteins
with EBs by 90%, as assessed by IF using the 4G10 antibody
(Figure 5A, panels D–F, and see Figure S1 for quantitation,
***p,0.001). In contrast, AG1295 did not inhibit C. trachomatis-
induced tyrosine phosphorylation of proteins associated with EBs
(Figure 5A, panels G–I, and Figure S1).
We confirmed the role of Abl kinases in phosphorylating EB-
associated proteins by examining tyrosine phosphorylation of C.
trachomatis-infected Abl/Arg2/2 cells or Abl siRNA-depleted HeLa
Figure 2. C. trachomatis infection induces phosphorylation of PDGFRb and recruitment of phospho-PDGFRb to the site of entry. (A)
PDGFRb was immunoprecipitated from C. trachomatis infected HeLa cells at 1 hpi in the absence or presence of STI571 and immunoblotted with
4G10 antibody. As a positive control, cells were stimulated with 100 ng/ml PDGF-BB. (B) EGFR was immunoprecipitated from C. trachomatis infected
HeLa cells at 1 hpi and immunoblotted with 4G10 antibody. As a positive control, cells were stimulated with 100 ng/ml EGF. (C) C. trachomatis
infected cells incubated in the absence (panels A–C) or presence of STI571 (panels D–F) or AG1295 (panels G–I) were fixed and stained with anti-
phospho-PDGFRb antibody (green in merge). Bacteria and host DNA were detected using DAPI (blue in merge). The exposure time for each filter of all
images was identical.
doi:10.1371/journal.ppat.1000021.g002
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cells. We observed a significant reduction in the number of
EBs associated with tyrosine phosphorylated proteins in the
Abl/Arg2/2 cells as compared to the 3T3 control cells (Figure 5B
and Figure S2; 75% reduction, ***p,0.001). Similar results were
observed when Abl kinase levels were depleted 85% by siRNA
(Figure S2; 60% reduction in EB-associated phospho-tyrosine
proteins compared to control siRNA-treated cells, ***p,0.001).
This result is similar to 3T3 cells (Figure S2) and control RNAi-
treated HeLa cells exposed to STI571 (Figure S2). Together, these
results suggest that Abl kinase and/or Abl kinase targets comprise
the majority of EB-associated tyrosine phosphorylated proteins.
Tyrosine phosphorylation was not entirely abolished in the Abl/
Arg2/2 cells, however the residual phosphorylation was less
intense (Figure 5B). These data indicate that there is also an Abl
kinase-independent pathway of tyrosine phosphorylation that most
likely involves PDGFRb.
To determine whether Abl kinase was sufficient for tyrosine
phosphorylation of EB-associated proteins, we examined phos-
phorylation in Abl/Arg2/2 cells transiently transfected with
Hemaglutinin (HA)-tagged Abl kinase. Expression of HA-Abl in
Abl/Arg2/2 cells restored tyrosine phosphorylation to similar
levels as those observed in 3T3 cells (Figure S3), whereas
expression of a control protein, enhanced green fluorescent
protein (EGFP), had no affect on tyrosine phosphorylation. Taken
together, these results indicate that Abl kinase is necessary and
sufficient for tyrosine phosphorylation of proteins at the site of EB
invasion.
Figure 3. PDGFRb contributes to C. trachomatis binding. (A) HeLa cells were transfected with control siRNA or siRNA targeting Abl kinase,
PDGFRb, or EGFR and subsequently infected with C. trachomatis for 1 hour. Cells were fixed and analyzed by inside out staining for the total cell-
associated bacteria (black bars) and the internalization efficiency (light grey bars). The data are expressed as the percentage of cell-associated
bacteria (which includes internalized and surface-associated bacteria) or as the internalization efficiency (the percentage of internalized EBs/total cell-
associated EBs). In each case, the data are normalized to control siRNA. ***p,0.001 for PDGFRb RNAi-treated cells compared to control RNAi-treated
cells (ANOVA). The percentage of cell-associated bacteria was significantly decreased only in cells depleted of PDGFRb, but not Abl kinase or EGFR. (B)
Western blot analysis of siRNA-treated samples. C, control; A, Abl; b, PDGFRb; E, EGFR. Control, Abl and PDGFRb samples were run on the same blot.
GAPDH was used as a loading control. The efficiency of protein depletion compared to control siRNA-treated cells is indicated to the right of each
panel. (C) HeLa cells were pretreated with control IgG or a neutralizing antibody to PDGFRb or EGFR at the indicated concentrations, subsequently
infected with C. trachomatis for 1 hour, and analyzed for total cell-associated EBs. Data for PDGFRb or EGFR neutralizing antibody was normalized to
the same concentration of each isotype matched IgG control and set at 100%. ***p,0.001 or **p,0.01 for cells pretreated with PDGFRb neutralizing
antibody compared to the same concentration of isotype matched IgG control (ANOVA). The percentage of cell-associated bacteria was significantly
decreased only in cells treated with a neutralizing antibody to PDGFRb but not EGFR. The small decrease in binding observed upon pretreatment
with 2 ug/ml of EGFR neutralizing antibody is not statistically significant.
doi:10.1371/journal.ppat.1000021.g003
Figure 4. Activated Abl kinase is recruited to EBs during entry.
HeLa cells were pretreated with DMSO (panels A–D), STI571 (panels E–
H), or AG1295 (panels I–L) for 1 hour and subsequently infected with C.
trachomatis in the presence of carrier or the indicated drug. The cells
were fixed and stained with antibody that recognizes endogenous Abl
kinase (panels A, E, and I; red in merge) and an antibody that recognizes
phospho-Abl Y412 (panels B, F, and J; green in merge). Bacteria and
host DNA were detected using DAPI (panels C, G, and K; blue in merge).
The merged panels are shown on the right (panels D, H, L). The
exposure time for each filter of all images was identical. PDGFR activity
is not required for recruitment and activation of Abl kinase.
doi:10.1371/journal.ppat.1000021.g004
Signaling during Chlamydia Entry
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Abl and PDGFR kinases function redundantly in C.
trachomatis entry
To determine whether activation of Abl kinase and/or
PDGFRb was necessary for C. trachomatis entry, we used three
complementary approaches to functionally inhibit PDGFR and
Abl kinase activities either individually or in combination: 1)
pharmacological inhibitors of PDGFR and Abl, 2) Abl/Arg2/2
cells, and 3) siRNA-treated HeLa cells. For these experiments, cells
were infected with C. trachomatis and then analyzed by inside out
staining to determine the total cell-associated EBs and internal-
ization efficiency. The percentage of cell-associated bacteria was
not significantly decreased with drug treatment (data not shown),
in Abl/Arg2/2 cells (data not shown), or when Abl kinase was
depleted by siRNA (Figure 3).
Pretreatment of HeLa cells with STI571 decreased C. trachomatis
internalization efficiency in a dose-dependent manner, with
maximal inhibition of approximately 40–50% compared to
DMSO-treated cells (Figure 6A). These results correlated with a
dose-dependent inhibition of Abl kinase activity with maximal
inhibition at 40 mM STI571 (Figure S4). As STI571 is highly
protein bound [54] and these experiments were of necessity
carried out in the presence of serum, these circumstances may
explain why higher doses of STI571 (ie 40 mm) were required for
maximal inhibition of Abl kinase activity and bacterial internal-
ization.
We next examined C. trachomatis internalization efficiency in
Abl/Arg2/2 cells or HeLa cells depleted of Abl by RNAi. No
reduction in internalization efficiency was observed in the Abl/
Arg2/2 cells compared to DMSO-treated 3T3 cells (Figure 6B).
Similarly, infection of HeLa cells in which Abl kinase levels were
decreased 85% by RNAi (Figure S2) did not affect C. trachomatis
internalization efficiency (Figure 6C). To assess the contribution of
PDGFR signaling during C. trachomatis entry, AG1295 was added
to control siRNA-treated HeLa cells or 3T3 cells. As shown in
Figure 6B and 6C, AG1295 had no significant effect on entry in
control siRNA-treated cells. However, addition of AG1295 to Abl
kinase depleted or to Abl/Arg2/2 cells diminished entry to a level
similar to what was observed with STI571 treatment (Figure 6B
and 6C). These results indicate that Abl and PDGFR kinases
function redundantly in entry. Since entry was not completely
abolished when Abl and PDGFR kinases were inhibited, other
kinases likely contribute to bacterial entry.
We determined whether Abl kinase was sufficient for entry by
examining the ability of a mutant version of Abl kinase that is
resistant to STI571 (Abl STI571R) to support C. trachomatis
internalization in the presence of STI571. This construct has a
mutation in the ATP-binding domain of Abl, T315I, which
interferes with STI571 binding to the active site [55]. We infected
HeLa cells expressing wild type Abl kinase (Abl WT) or Abl
STI571R in the presence or absence of STI571 and measured
internalization efficiency. A parallel set of cells was assessed for C.
trachomatis-induced activation of Abl kinase. As shown in Figure 7A,
STI571 blocked recruitment of phosphorylated Abl kinase to the
site of EB binding in cells transfected with Abl WT but not in cells
expressing Abl STI571R, confirming that this allele is resistant to
STI571. Addition of STI571 to cells transfected with Abl WT
resulted in approximately a 50% decrease in internalization
efficiency, similar to its observed inhibition of C. trachomatis entry in
cells expressing endogenous Abl (Figure 6). In contrast, transfec-
tion with Abl STI571R permitted bacterial internalization in the
presence of STI571 (Figure 7B). These results indicate that Abl
kinase is sufficient to support C. trachomatis entry.
Abl kinase and PDGFR signal to overlapping downstream
effectors
In our S2 screen, we identified several tyrosine-phosphorylated
proteins that are important for Rac-dependent actin remodeling
and are known to be downstream of Abl kinase and PDGFR [20–
26]. These include WAVE, Abelson interactor protein (Abi), Vav,
and Cortactin. Interestingly, WAVE2 and Cortactin, activators of
the Arp2/3 complex that nucleates actin, have been previously
shown to colocalize with EBs [15,19,56]. Vav has not been
previously implicated in C. trachomatis entry. Vav proteins have a
number of domains, including pleckstrin homology (PH), DBL-
homology (DH), SH2, SH3, and proline-rich domains, that allow
them to function as guanine nucleotide exchange factors for Rac/
Rho GTPases as well as scaffolding proteins (reviewed in [57]).
Tyrosine phosphorylation of WAVE, Vav, and Cortactin closely
correlates with their activation. Abl kinase has been shown to
phosphorylate both WAVE2 and Cortactin upon PDGF stimula-
Figure 5. Abl Kinase is necessary for tyrosine phosphorylation
of proteins associated with EBs. (A) HeLa cells were pretreated with
DMSO (panels A–C), STI571 (panels D–F), or AG1295 (panels G–I) for
1 hr, infected with C. trachomatis, and phospho-tyrosine-associated
proteins detected by staining with 4G10 (panels A, D, and G; red in
merge). Bacteria and host DNA were detected using DAPI (panels B, E,
and H; blue in merge). The exposure time for each filter of all images
was identical. STI571 but not AG1295 inhibits EB-associated tyrosine
phosphorylation. (B) HeLa, NIH 3T3, and Abl/Arg2/2 cells were infected
with C. trachomatis for 1 hour and then stained with 4G10 (panels A, D,
G; green in merge). Actin was stained with phalloidin (panels C, F, I; red
in merge). Bacteria and host DNA were detected using DAPI (panels B,
E, H; blue in merge). The exposure time for each filter of all images was
identical. EB-associated tyrosine phosphorylation is diminished in Abl/
Arg2/2 cells.
doi:10.1371/journal.ppat.1000021.g005
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Figure 6. Abl kinase and PDGFR function redundantly in C. trachomatis entry. (A) HeLa cells were pretreated with DMSO or the indicated
concentration of STI571 for 1 hr and subsequently infected with C. trachomatis in the presence of DMSO or STI571. Cells were fixed, stained, and
analyzed for C. trachomatis internalization efficiency as described in Materials and Methods. Values (mean6s.e.m.) are shown as percentage of
internalized EBs/total cell-associated EBs and normalized to DMSO-treated-HeLa cells. Data are from at least 3 independent experiments. *p,0.05 for
cells treated with 20 mM STI571 compared to DMSO-treated cells. ***p,0.001 for cells with 40 mM STI571 compared to DMSO-treated cells (ANOVA).
(B) NIH 3T3 or Abl/Arg2/2 cells were pretreated with DMSO, STI571, or AG1295 for 1 hour and subsequently infected with C. trachomatis in the
presence of carrier or drug. Cells were fixed, stained, and analyzed for Chlamydia internalization efficiency as described in Materials and Methods.
Values (mean6s.e.m.) are shown as percentage of internalized EBs/total EBs normalized relative to the DMSO control for each cell type. Data are from
at least 3 independent experiments. There was no significant decrease in internalization efficiency in DMSO-treated Abl/Arg2/2 cells or AG1295-
treated 3T3 cells compared to DMSO-treated 3T3; however, there was a significant reduction in internalization efficiency when PDGFR activity was
inhibited in Abl/Arg2/2 cells and in STI571-treated cells. ***p,0.001 and **p,0.01 (ANOVA). (C) Control or Abl siRNA-treated HeLa cells were
pretreated with DMSO, STI571, or AG1295 for 1 hour and subsequently infected with C.trachomatis in the presence of carrier or drug. Cells were fixed,
stained, and analyzed for C. trachomatis internalization efficiency as described in Materials and Methods. Values (mean6s.e.m.) are shown as
percentage of internalized EBs/total cell-associated EBs. All samples are normalized to DMSO-treated control siRNA cells. Data are from two
independent experiments. There was no significant decrease in internalization efficiency in DMSO-treated Abl siRNA-treated cells or AG1295-treated
control siRNA cells compared to DMSO-treated control siRNA-treated cells; however, there was a significant reduction in internalization efficiency
when PDGFR activity was inhibited in Abl siRNA-treated cells and in STI571-treated cells. ***p,0.001, **p,0.01, and *p,0.05 (ANOVA).
doi:10.1371/journal.ppat.1000021.g006
Figure 7. Abl kinase is sufficient for C. trachomatis entry. HeLa cells were transfected with Abl kinase (Abl WT) or an STI571 resistant allele of
Abl kinase (Abl STI571R), treated with STI571, and then infected with C. trachomatis for 1 hour. (A) Cells were fixed and stained with an antibody that
recognizes phosphorylated Abl kinase (green) and DAPI to identify bacteria (blue). The exposure time for each filter of all images was identical.
Transfection of Abl STI571R (panel D) but not wild type Abl (panel B) permits recruitment of phospho-Abl in the presence of STI571. (B) A parallel set
of cells were fixed, stained, and analyzed for C. trachomatis internalization efficiency as described in Materials and Methods. The internalization
efficency (mean6s.e.m.) is the percentage of internalized EBs/total cell-associated EBs. Data are representative of three independent experiments.
Samples are normalized to DMSO-treated cells. Expression of Abl STI571R permits internalization in the presence of STI571. **p,0.01 for STI571-
treated Abl WT cells compared to DMSO-treated Abl WT cells. *p,0.05 for STI571-treated Abl WT cells compared to STI571-treated Abl STI571R cells
(ANOVA).
doi:10.1371/journal.ppat.1000021.g007
Signaling during Chlamydia Entry
PLoS Pathogens | www.plospathogens.org 7 2008 | Volume 4 | Issue 3 | e1000021
tion [24–26] while Vav1 is a substrate of the oncogenic chimeric
Bcr-Abl protein [58]. Vav2, the more ubiquitiously expressed form
of Vav, has been shown to be a substrate of PDGFR [23]. Using
immunoblot analysis in conjunction with Abl depletion and/or the
PDGFR inhibitor, AG1295, we determined whether C. trachomatis
infection induced phosphorylation of WAVE2, Vav2, and
Cortactin in an Abl kinase and/or PDGFR-dependent manner
in mammalian cells.
We first tested whether WAVE2, Vav2, and Cortactin were
tyrosine phosphorylated upon C. trachomatis infection. L2 infection
of HeLa cells induced tyrosine phosphorylation of WAVE2, Vav2,
and Cortactin at 1 hour post infection (Figure 8, lane 2). In
addition, phospho-Vav2 and phospho-Cortactin were recruited to
the site of EB entry (data not shown). Tyrosine phosphorylation of
WAVE2 and Cortactin was diminished (at least 3-fold) when Abl
kinase was depleted (Figure 8, lane 5) or when PDGFR was
inhibited by AG1295 (Figure 8, lane 3), indicating that Abl kinase
and PDGFR are required for phosphorylation. Simultaneous
inhibition of both Abl kinase and PDGFR (Figure 8, lane 6) did
not further decrease WAVE2 and Cortactin phosphorylation. In
contrast, depletion of Abl kinase or inhibition of PDGFR had a
more modest effect onVav2 phosphorylation (1.5–2-fold; Figure 8,
lanes 3 and 5) but appeared to have an additive effect when both
pathways were simultaneously affected (Figure 8, lane 6).
Together, these results indicate that in the context of C. trachomatis
infection, activation of either the Abl kinase or the PDGFR
pathway leads to activation and increased tyrosine phosphoryla-
tion of WAVE2, Vav2, and Cortactin. Consistent with these
results, we observed that in cells treated with STI571, phosphor-
ylation of WAVE2, Vav2, and Cortactin was significantly
diminished (Figure S5) and recruitment of phospho-Vav2 and
phospho-Cortactin to EBs was impaired (data not shown).
Tyrosine phosphorylation of WAVE2, Vav2, and Cortactin was
not entirely abolished when Abl and PDGFR were simultaneously
inhibited, suggesting that there are also Abl- and PDGFR-
independent pathways of tyrosine phosphorylation.
TARP is phosphorylated by Abl kinases
TARP is a bacterial-encoded actin nucleator likely secreted by
the Chlamydia type III secretion system upon binding and is
tyrosine phosphorylated by an as yet unidentified host kinase [19].
C. trachomatis L2 TARP possesses six direct repeats of approx-
imately 50 amino acids each, and the majority of tyrosine residues
are found within this region [17]. Analysis of the repeat region
revealed the presence of 2 potential consensus Abl kinase target
sequence motifs (E N I Y E S I D and E N I Y E N I Y) [59]
(Figure 9A). To test whether TARP is a target for Abl kinase, we
analyzed the phosphorylation and localization of transiently
transfected enhanced green fluorescent protein fused to TARP
(EGFP-TARP) in 3T3 and Abl/Arg2/2 cells by IF microscopy.
Consistent with previous reports [16], we observed that transfected
EGFP-TARP forms aggregates within the cytoplasm, is tyrosine
phosphorylated, and recruits actin (Figure 9B). A qualitative
reduction in the amount of tyrosine phosphorylation of EGFP-
TARP in the Abl/Arg2/2 cells compared to the parental cells was
noted (Figure 9B). In addition, TARP appeared more dispersed
with fewer aggregates and localized to the cell periphery in Abl/
Arg2/2 cells.
To rule out the possibility that the apparent decrease in TARP
phosphorylation was an artifact of its more diffuse staining or
varying levels of expression, parental or Abl/Arg2/2 cells
ectopically expressing EGFP-TARP were immunoblotted with
4G10 for a quantitative analysis of phosphorylation. We controlled
for differences in transfection efficiency by determining the ratio of
phosphorylated EGFP-TARP to total EGFP-TARP by densitom-
etry analysis in each cell type. There was a significant reduction in
EGFP-TARP phosphorylation in the Abl/Arg2/2 cells compared
to control cells (Figure 9C; **p,0.01 (ANOVA)). Further support
of a role for Abl kinase in TARP phosphorylation was evident by
the co-localization of EGFP-TARP and endogenous Abl kinase
(Figure S6).
Despite a change in phosphorylation and localization for EGFP-
TARP in the absence of Abl family kinases, actin was still recruited
to EGFP-TARP regardless of cell type (Figure 9B). Since bacteria
enter Abl/Arg2/2 cells as efficiently as wild type, this finding
suggests that either Abl-mediated TARP phosphorylation is
dispensable for entry or that the residual Abl-independent
phosphorylation observed is sufficient for actin recruitment and
bacterial entry.
Discussion
Understanding the mechanisms that Chlamydia species use to
gain entry into host cells is complicated by the ability of this
obligate intracellular pathogen to enter host cells via multiple
routes and by the inability to carry out classical bacterial genetics.
In this study, we have circumvented these obstacles by using RNAi
to carry out a large scale forward genetic screen in D. melanogaster, a
surrogate host with less functional redundancy, to identify host
proteins required for early steps in C. trachomatis infection. Our
screen confirmed some previously known host targets and has,
Figure 8. Abl kinase and PDGFR signal to overlapping
downstream effectors. HeLa cells were transfected with control or
Abl kinase siRNA for 48 hours, treated with DMSO or AG1295 for 1 hour,
and then subsequently infected with C. trachomatis for 1 hour. WAVE2
and Cortactin were immunoprecipitated from lysates and subjected to
western blot analysis with 4G10 to assess phosphorylation. Blots were
reprobed for total protein amounts. Lysates from the same set of
samples were probed with anti-pVav2, total Vav2, total Abl, and GAPDH
(loading control) antibodies. The percentage of phosphorylated protein
compared to total protein was quantified by densitometry analysis and
normalized relative to C. trachomatis-infected samples. Immunoblots
shown are representative of three independent experiments. C.
trachomatis induces phosphorylation of WAVE2, Vav2, and Cortactin
(lane 2). Inhibition of PDGFR or Abl signaling decreases WAVE2, Vav2,
and Cortactin phosphorylation.
doi:10.1371/journal.ppat.1000021.g008
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most importantly, identified for the first time the activation of
PDGFR and Abl kinase signaling pathways as key events in the
pathogenesis of C. trachomatis infections. We demonstrate that in
mammalian cells, PDGFRb functions as a receptor for C.
trachomatis binding and that once bound, bacterial internalization
can occur either through activation of PDGFRb or through
independent activation of Abl kinase. Activation of these kinases
culminates in phosphorylation of the Rac guanine nucleotide
exchange factor, Vav2, and several actin nucleators, including
WAVE2 and Cortactin, that ultimately promote efficient uptake of
this obligate intracellular parasite.
The initial step in Chlamydia binding is thought to be a
reversible, electrostatic interaction with heparan sulfate-like
glycosaminoglycans followed by an irreversible interaction with
an unknown receptor [60]. We provide compelling data that at
least one receptor for C. trachomatis binding is PDGFRb. We
demonstrate that RNAi-mediated depletion of PDGFRb or
addition of a neutralizing antibody to PDGFRb significantly
decreases bacterial binding to mammalian cells. Consistent with its
role as a receptor, phosphorylated PDGFRb is recruited to the site
of EB binding.
There are several possible models to explain the interactions
between C. trachomatis and PDGFRb. The bacterium may bind
directly to PDGFRb. Alternatively, the interactions may be
indirect. For example, EBs could bind directly to the growth
factor receptor ligand (PDGF), which would in turn facilitate
binding and activation of PDGFRb. Another possible scenario is
that heparan sulfate (either on the surface of C. trachomatis or on the
surface of host cells) could bind to PDGF, facilitating subsequent
interaction with PDGFRb. Finally, EBs, heparan sulfate, PDGF,
and PDGFRb could form a complex, with heparan sulfate and
PDGF serving as bridging molecules. Although EGFR was not
involved in C. trachomatis binding to host cells under our
experimental conditions, suggesting specificity for PDGFRb we
cannot rule out a possible role for other growth factor receptor
interactions.
The biological properties of PDGFRb fit well with the known
characteristics of EB binding and entry. The receptors are
ubiquitously expressed in cultured cells, consistent with the known
ability of C. trachomatis to enter most cell types in vitro. PDGFRb is
known to be highly expressed in the uterus and ovaries as well as in
macrophages, tissues and cells susceptible to C. trachomatis
infections in vivo [61]. PDGFRb internalization occurs by both
clathrin-dependent and clathrin-independent pathways (reviewed
in [62]), consistent with the reported diversity in C. trachomatis
internalization mechanisms (reviewed in [60]). PDGFRb signals to
regulators of the actin cytoskeleton [22–26] that are activated in
response to C. trachomatis infection, including Vav2 (this work),
Cortactin (this work), WAVE2 (this work and [56]), and Rac
[56,63]. PDGF can bind heparan sulfate proteoglycans, and this
interaction can enhance PDGF-induced signaling of PDGFR
[64,65], potentially explaining the contribution of this heparan
sulfate to Chlamydia binding. Finally, activation of and entry
through a growth factor receptor pathway may serve to promote
host cell survival and prevent apoptosis early during infection,
which is vital for the successful growth and dissemination of an
obligate intracellular parasite. Indeed, the phosphatidylinositol-3
kinase (PI3K) pathway contributes to resistance of C. trachomatis
infected cells to apoptosis [66], although the mechanism by which
this pathway is activated remains to be determined. Since PDGFR
Figure 9. TARP is a substrate for Abl family kinases. (A) The putative TARP consensus tyrosine phosphorylation sites are compared to the Abl
kinase consensus target sequence. C. trachomatis TARP contains six copies of a ,50 amino acid repeat. Each repeat region encodes either motif I or
motif II with 1 or 2 potential tyrosine phosphorylation sites (indicated with an asterisk). Highlighted residues indicate the high homology of the TARP
motifs to consensus Abl kinase target substrates at positions23,21, +1, and +4. (B) HeLa, NIH 3T3, and Abl/Arg2/2 cells were transfected with EGFP-
fused to TARP and incubated for 24 hours (green; panels B, E, H). Cells were then fixed and tyrosine phosphorylated TARP was stained with 4G10 (red;
panels A, D, G) and actin was stained with phalloidin (blue; panels C, F, I). The exposure time for each filter of all images was identical. Tyrosine
phosphorylation of TARP is significantly decreased in Abl/Arg2/2 cells. (C) Immunoblots of protein extracts from NIH 3T3 and Abl/Arg2/2 cells
transfected with EGFP-TARP were probed with antibodies to 4G10, GFP, or actin (loading control). The fraction of phosphorylated TARP compared to
total TARP was quantified by densitometry analysis for both cell types. Immunoblots shown are representative of three independent experiments.
There was a significant reduction in the total TARP phosphorylated in the Abl/Arg2/2 cells compared to the 3T3 cells, **p,0.01 (ANOVA).
doi:10.1371/journal.ppat.1000021.g009
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can exert an antiapoptotic effect in a PI3K-dependent manner
[67], we speculate that bacterial binding to PDGFRb may activate
the PI3K pathway.
The results presented here indicate that C. trachomatis binding
leads to activation of PDGFRb and Abl kinase signaling pathways,
which operate in a redundant manner to ensure failsafe and
efficient uptake of this obligate intracellular parasite into
mammalian cells. While inhibition of either Abl kinase or PDGFR
alone has a minimal effect on bacterial entry, inhibition of both
kinases either by STI571 treatment or by inhibiting PDGFRb in
cells where Abl is deleted or depleted significantly decreases
internalization. Furthermore, a STI571-resistant allele of Abl
kinase is capable of supporting entry in the presence of drug,
indicating that Abl kinase alone is sufficient for entry. We note that
in S2 cells, depletion of Abl kinase alone is sufficient to decrease
vacuole formation. This may reflect the absence of functional
redundancy in Drosophila or may indicate an additional essential
role for Abl kinase in post-entry events.
Our results indicate that during infection, C. trachomatis-induced
activation of PDGFRb is not necessary for activation of Abl kinase
even though PDGFRb signaling has been shown to activate Abl
kinase in other settings [44,68,69]. How Abl kinase is activated
upon EB binding remains to be determined. Abl kinase activation
may occur through activation of another as yet unidentified
surface receptor or it may be activated by TARP or other
translocated bacterial effectors [70,71].
Our work demonstrates that C. trachomatis infection leads to
tyrosine phosphorylation and recruitment of several key molecules
involved in Rac-dependent actin rearrangements that are known
to be regulated by PDGFR and Abl kinase [20–26,72–75]. These
include Vav2, a Rac GEF as well as WAVE2 and Cortactin,
activators of the Arp2/3 complex in the Rac pathway. Although
our IF data using the 4G10 antibody (Figures 5 and 6) suggests
that Abl kinase is the major kinase responsible for phosphorylating
EB-associated proteins, our western blot data (Figure 8) indicates
that PDGFR activity also contributes to tyrosine phosphorylation
of WAVE2, Vav2, and Cortactin. Since Abl kinase and PDGFR
function redundantly for C. trachomatis entry, the indispensable role
of Abl kinase in tyrosine phosphorylation of EB-associated proteins
and the dispensable role of Abl in C. trachomatis invasion can be
explained by: (i) Abl kinase may phosphorylate a large fraction of
EB-associated proteins, while PDGFR phosphorylates a subset of
functionally redundant proteins, (ii) some of the proteins
phosphorylated by Abl kinase may have multiple tyrosine residues
(such as TARP), making Abl appear to be the major kinase, and/
or (iii) not all Abl targets play a role in entry.
To our knowledge, Vav2 has not been previously implicated in
C. trachomatis infection. We have previously observed co-localiza-
tion of Cortactin with inclusions [15]. While this manuscript was
in preparation, Hybiske et al reported that depletion of Cortactin
results in a modest decrease in entry [76], and Carrabeo et al
demonstrated that WAVE2 and Arp3 colocalize with EBs and are
required for entry [56]. We now link these signaling cascades
involving Rac and Arp2/3 activators to upstream events that
include EB binding to and activation of PDGFR as well as
activation of Abl kinase. We conclude that activation of Abl kinase
and PDGFR are necessary to ensure efficient recruitment and
activation of downstream signaling molecules, including WAVE2,
Vav2, and Cortactin, which mediate actin polymerization and
entry.
The exact relationship between Abl activation, phosphorylation
of the putative type III secreted effector TARP, entry, and vacuole
formation is likely to be complex. Though our findings
demonstrate that Abl kinase phosphorylates TARP, inhibition of
Abl kinase by several different methods did not prevent entry. One
explanation for this result is, as suggested by others [16,19], that
TARP phosphorylation is not required for entry; instead, it could
be important for a post entry function, such as inclusion trafficking
and/or fusion. This observation could explain why the signifi-
cantly diminished phosphorylation of EBs in Abl/Arg2/2 cells did
not affect entry, especially given that TARP encodes many
tyrosine residues that could serve as putative phosphorylation sites.
Alternatively, TARP phosphorylation was not completely abol-
ished in the Abl/Arg2/2 cells, suggesting that other tyrosine
kinases, such as Src family kinases, may target TARP. This
residual TARP phosphorylation could be sufficient to mediate
bacterial entry. Interestingly, Src family kinases can be activated
by PDGFR signaling and regulate cytoskeletal dynamics (reviewed
in [77]), thus the PDGFR-Src pathway could function redundantly
with Abl kinase to promote entry.
We speculate that Abl-dependent phosphorylation of TARP
may provide docking sites for recruitment of additional SH2
containing signaling molecules that may increase the efficiency of
entry. This could include setting up a positive feedback pathway
similar to what has been recently reported for Tir phosphorylation
during pedestal formation by Enteropathogenic Escherichia coli
[78]. Initial phosphorylation of TARP would lead to recruitment
of additional kinase molecules as well as new TARP molecules,
culminating in the recruitment of actin and actin polymerizing
factors [78]. Alternatively, by virtue of its four polyproline motifs
(PxxxP) [19], TARP could bind to the SH3 domains of both Vav2
and Abl kinase. This interaction would serve to bring Abl kinase in
contact with Vav2 and ensure efficient Rac activation, a
mechanism that has been proposed for Vav activation by the
Murine gamma-herpesvirus 68 latency protein M2 [79]. It is also
possible that key role of Abl kinase during entry is to
phosphorylate and/or recruit other actin polymerization media-
tors (i.e. WAVE2, Vav2, and Cortactin).
The modulation of signaling pathways involving Abl kinase and
bacterial internalization is an emerging theme among important
human pathogens, including Shigella flexneri [80] and Group B
coxsackievirus [81]. In contrast to these pathogens where Abl
kinase is the only kinase required for entry, our findings
demonstrate that entry can occur either via an Abl kinase-
dependent pathway or through activation of PDGFRb. Our
results further suggest that these two pathways function in parallel
and are thus functionally redundant. Since STI571 can inhibit
both Abl and PDGFR kinases, this finding may explain why
bacterial entry is diminished with this drug but unaffected in Abl/
Arg2/2 cells. Although we cannot rule out the possibility that
other STI571-inhibitable kinases play a role in C. trachomatis entry,
such as c-Fms and Lck kinase [82,83], these targets are not, to the
best of our knowledge, expressed in HeLa or NIH 3T3 cells, [84–
87]). Furthermore, the fact that we can recapitulate the entry
defect observed with STI571 by depleting Abl kinase and
inhibiting PDGFR in the same cell using alternative means (ie.
Treatment of Abl/Arg2/2 with AG1295, a specific PDGFR
inhibitor) provides compelling evidence that these proteins are
likely the main kinases affected by STI571 in the context of C.
trachomatis entry.
Our results are consistent with the following model for C.
trachomatis entry into host cells (Figure 10). C. trachomatis L2 binds to
and activates PDGFRb, possibly via heparan sulfate and/or
PDGF. Abl kinase is recruited to and activated at the site of EB
binding in a PDGFR-independent manner and phosphorylates
TARP. Activation of PDGFR and Abl kinase leads to recruitment
and activation of downstream targets, including Vav2, WAVE2,
and Cortactin. Rac and Arp 2/3 are recruited to the site of entry.
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Actin polymerization is stimulated through the WAVE2/Arp2/3
pathway, Cortactin/Arp2/3 pathway, and/or directly by TARP.
Since binding and entry of C. trachomatis was not completely
abolished under our experimental system, this bacterium most
likely utilizes other receptors and pathways that converge with
these molecules to ensure efficient Rac and Arp2/3 activation for
Chlamydia uptake. In addition, Abl-dependent TARP phosphory-
lation may contribute to critical events after entry that are required
for this obligate intracellular parasite to survive and replicate in the
host cell.
In summary, we have applied a genome-wide RNAi-based
forward genetic screen to discover that C. trachomatis hijacks
PDGFRb and Abl kinase to modulate the host cytoskeleton in
order to efficiently to enter host cells.
Materials and Methods
Reagents
Cholesterol, Methyl-beta-cyclodextrin (MbCD), heparin, and
Concanavalin A (ConA) were purchased from Sigma-Aldrich.
Recombinant human PDGF-BB and EGF were purchased from
R&D Systems. AG1295 was obtained from Calbiochem. The
concentration for AG1295 and STI571 was 40 mM, unless
otherwise indicated, as these doses provided maximal inhibition
without affecting cell viability. GFP-TARP construct was a kind
gift from R. Carabeo and has been previously described [16]. The
pIRESSKII EGFP (Clontech), with bases 1870–1910 removed,
has been described previously [88]. HA-tagged Abl, untagged wild
type Abl, and untagged Abl STI571R (also known as Abl-T351)
have been previously described [55]. Antibodies were obtained
from the following sources: mouse anti-Chlamydia FITC conjugate
(Meridian Diagnostics), goat anti-C. trachomatis MOMP (Cortex
Biochem), rabbit anti-Chlamydia LPS (Cortex Biochem), mouse
anti-GAPDH (Chemicon), goat anti-actin (Santa Cruz), rabbit
anti-PDGFRb (Santa Cruz), goat anti-PDGFRb (R&D), rabbit
anti-phospho-PDGFRb (Tyr751) (Cell Signaling), rabbit anti-
EGFR (Santa Cruz), mouse anti-Abl (Santa Cruz), rabbit anti-Abl-
pY412 (Cell Signaling Technology), mouse anti-4G10 (Upstate),
mouse anti-Cortactin (Upstate), rabbit anti-Vav2 (Santa Cruz),
goat anti-WAVE2 (Santa Cruz), mouse anti-gfp (Roche), mouse
and rabbit anti-HA (Roche), mouse anti-gfp (Roche), mouse anti-
Crk (BD Transduction), rabbit anti-CrkII (Tyr221) (Cell Signal-
ing), rabbit anti-goat IgG HRP (Calbiochem), goat anti-rabbit IgG
HRP (Amersham Biosciences), goat anti-mouse IgG HRP
(Amersham Biosciences), donkey anti goat Alexa 594 (Molecular
Probes), chicken anti-mouse 594 (Molecular Probes), donkey anti-
goat Alexa 488 (Molecular Probes), and donkey anti-rabbit Alexa
488 (Molecular Probes). Texas red- or Alexa 350-conjugated
phalloidin were obtained from Molecular Probes. All siRNA’s
were obtained from Santa Cruz Biotechnology, Inc: Abl kinase (sc-
29843), PDGFRb (sc-29442), EGFR (sc-29301), and Control
siRNA-A (sc37007).
Cell culture and C. trachomatis propagation
HeLa 229 cells and L929 cells were obtained from ATCC and
passaged as previously described [89]. NIH 3T3 cells were
obtained from ATCC. 3T3 cells derived from Abl/Arg2/2 mice
[49] were maintained at 37uC with 5% CO2 in DMEM containing
20% Fetal Bovine Serum (FBS). Drosophila S2 cells were kind gifts
of Ron Vale (UCSF) and cultured in Schneider’s medium
supplemented with 10% FBS. C. trachomatis serovar LGV L2 was
propagated in L929 cells. C. trachomatis EBs were harvested from
infected cells and purified using a renografin step-gradient
essentially as described [90].
RNAi screen
The dsRNA library used in this screen has been described
previously [28]. S2 cells were placed into 96-well plates at a density
Figure 10. Model for C. trachomatis binding and internalization. EBs bind to and activate PDGFRb, possibly via heparan sulfate and/or PDGF.
Abl kinase is recruited to and activated at the site of EB binding in a PDGFRb-independent manner and phosphorylates TARP. The combined
activation of PDGFRb and Abl kinase leads to phosphorylation and activation of Vav2, WAVE2, and Cortactin. Rac and Arp 2/3 are recruited to the site
of entry, possibly through interaction with TARP or via PDGFRb and/or Abl kinase signaling. Actin polymerization is stimulated through the WAVE2/
Arp2/3 pathway, Cortactin/Arp2/3 pathway, and/or directly by TARP. Other receptors and pathways converge and/or synergize with these molecules
to ensure efficient Rac and Arp2/3 activation for C. trachomatis uptake.
doi:10.1371/journal.ppat.1000021.g010
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of 40,000 cells per well in a culture volume of 150 ml per well.
dsRNA was added to a final concentration of 10 mg/ml, and the
cells were incubated for four days at 28uC to allow for depletion of
the corresponding gene product. For primary and secondary
screens, 16105 dsRNA-treated S2 cells were replated in 96-well
plastic plates. S2 cells were infected with C. trachomatis L2 (MOI of
,100) in the presence of 50 mMMbCD-cholesterol and incubated
at 28uC. After 1 h of infection, bacteria were removed, cells were
rinsed with Phosphate Buffered Saline (PBS), fresh media
supplemented with 1 mg/ml heparin was added, and cells were
incubated for 48 hours. The Chlamydia-infected S2 cells were
replated onto ConA-coated glass bottom 96 well dishes and
allowed to adhere for 30 min, washed with PBS, fixed in ice-cold
Methanol for 5 min, stained with anti-Chlamydia antibody
conjugated to FITC for 1h, and counterstained with Evan’s blue
to visualize cells. Infected cells were visually screened for an
apparent increase or decrease in vacuole formation, and changes
in cell number were also noted. For secondary screens, two
investigators screened wells independently and discrepancies were
resolved with further analysis.
Immunofluorescence studies
HeLa, NIH 3T3, and Abl/Arg2/2 cells were grown on glass
coverslips in 24 well plates and infected with C. trachomatis as
described in the text. Cells were fixed in 4% paraformaldehyde
(PFA) and permeabilized with 0.1% Triton containing 0.05%
sodium dodecyl sulfate-polyacrylamide (SDS). After blocking in
1% bovine serum albumin/PBS, cells were incubated with the
appropriate antibody for 1 hour, washed three times, and
incubated for 2 hours with the appropriate fluorophore-conjugat-
ed secondary. Coverslips were mounted in Vectashield mounting
media containing DAPI (Vector Laboratories) to identify bacteria
and host cell nuclei. Images for all immunofluorescent studies were
acquired at a magnification of 61,000 under oil immersion or
6400 with a Nikon Eclipse TE2000-E fluorescence microscope,
using a CCD camera and processed by Simple PCI imaging
software (Compix, Inc.). For each set of experiments, the exposure
times were identical for all images. Images were processed with
Adobe Photoshop CS.
Immunoprecipitation
Cells were lysed in lysis buffer (50 mM Tris HCl, pH 7.5,
150 mM NaCl, 0.1% SDS, 1% Nonidet P-40, 1% sodium
deoxycholate, 1mM sodium orthovanadate, 1 mM sodium
fluoride, 1 mM okadaic acid, and Complete protease inhibitors:
Roche Diagnostics). After centrifugation at 20, 800 g for 5 minutes
to remove cell debris, the supernatants were transferred to fresh
tubes. Supernatants containing the indicated antibody preconju-
gated to Protein G Sepharose TM 4 Fast Flow (GE HealthCare)
were incubated for 1 h at 4uC with gentle rocking. Immunopre-
cipitates were recovered by centrifugation, washed 3 times in lysis
buffer, eluted by boiling in SDS sample buffer, and immuno-
blotted.
Immunoblot analysis
Proteins were separated on 8% or 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) gels and trans-
ferred to 0.45 mm Trans-blot nitrocellulose membranes (BioRad
Laboratories). Membranes were blocked with 3% milk (Upstate)
and probed with the indicated antibodies. Proteins were detected
by ECL (Amersham Biosciences) according to the manufacturer’s
protocol. For quantitation, bands were analyzed using Image-
Quant software (Molecular Dynamics, Foster City, CA).
RNAi in mammalian cells
HeLa cells grown in 6 well plates were transfected with the
indicated siRNA (Santa Cruz) according to manufacturer’s
protocol and incubated for 24 hours. For phosphorylation assays,
siRNA-treated cells were trypsinized following the 24 hour
incubation, and replated into 24 well plates containing glass
coverslips. At 40 hours post transfection, cells were infected with
Chlamydia as described above and either analyzed for EB-
associated tyrosine phosphorylation by 4G10 antibody staining,
assessed for internalization efficiency as described above, or
subjected to immunoblot analysis or immunoprecipitation with the
indicated antibody. In some cases, cells were pretreated with
STI571 or AG1295 for 1 hour prior to and during infection. A
portion of the siRNA-treated cells was immunoblotted to
determine efficiency of protein depletion.
Phosphorylation assay
HeLa, NIH 3T3, and Abl/Arg2/2 cells were grown on glass
coverslips in 24 well plates and infected with C. trachomatis. For
immunofluorescence analysis of EB-associated tyrosine phospho-
proteins, cells were fixed in 4% paraformaldehyde (PFA) and
permeabilized with 0.1% Triton containing 0.05% SDS. After
blocking in 1% bovine serum albumin/phosphate-buffered saline
(PBS), cells were incubated with 4G10 antibody for 1 hour. Cells
were washed three times and then incubated for 2 hours with the
fluorophore-conjugated anti-mouse secondary and in some cases,
fluorophore-conjugated phalloidin. Coverslips were mounted in
Vectashield mounting media containing DAPI (Vector Laborato-
ries) to identify bacteria. For quantitation of EB-associated
phosphorylation, images were obtained from either Texas red
and DAPI or FITC and DAPI channels, depending on the
fluorophore used. Merged channels were analyzed. Total EBs
from the DAPI channel were enumerated and the efficiency of
phosphorylation was calculated using the formula (Single channel
(red or green)/total EBs)6100. A minimum of 5 fields containing
an average of 9 cells was analyzed per treatment. The date was
compiled from 3 experiments and is presented as means6standard
error.
Inside out staining
Inside out staining was performed as described in [11,91] with
modifications. Cells were grown overnight on glass coverslips in 24
well plates, drug-treated as indicated in the text or siRNA-treated
as described above, and subsequently infected with Chlamydia at an
MOI= 10 for 1 hour at 37uC to allow for attachment and
internalization. For antibody inhibition assays, cells were prein-
cubated with the indicated neutralizing antibody or the isotype-
matched control antiserum for 1 hour prior to addition of
bacteria. Infected cells were washed in PBS and fixed in 1%
PFA, gentle conditions that prevent permeabilization of the host
cell. After fixation, cells were blocked in 2% FBS/1% Fish Skin
Gelatin (FSG)/PBS for 1 hour and then incubated with goat anti-
MOMP antibody for 1 hour followed by incubation with donkey
anti-goat Alexa 488 antibody to stain external EBs. Cells were
then permeabilized with 0.1% Triton X-100, blocked again, and
incubated with rabbit anti-Chlamydia LPS antibody followed by
incubation with goat anti-rabbit Alexa 594 antibody to stain
intracellular and extracellular EBs. The host cell was visualized by
staining the actin cytoskeleton with phalloidin-Alexa 350 to
visualize the cell. The coverslips were then mounted and visualized
by immunofluorescence microscopy as described above. All
internalization and binding assay images were acquired with a
Nikon TE-2000E microscope using a 1006objective and saved in
RGB 24-bit tiff format. Images were collected form Texas-red,
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FITC and DAPI channels and merged. Merged images were
imported into Adobe Photoshop V.8 where the Pencil tool was
used to mask all bacteria that were not cell-associated. Enhanced
images were analyzed using MetaMorph (Molecular Devices,
Sunnyvale, CA). In MetaMorph, merged images were first
separated using an RGB Color Separator into three 8-bit
monochrome tiff images (Texas Red, FITC and DAPI). The
Image Multiplication function was then used to create two 16-bit
tiff images from the Texas Red and FITC channels (one Texas
Red-Texas Red multiplication and one Texas Red-FITC
multiplication). The 16-bit images were analyzed with the Count
Nuclei function and a grey level setting above background ranging
from 12,000 to 18,000, depending on the level of contrast and
signal strength. The Texas Red-Texas Red multiplication was
scored as total cell-associated EBs, whereas the Texas Red-FITC
multiplication was scored as extracellular EBs. The efficiency of
internalization was calculated using the formula ((Texas Red-
Texas Red2Texas Red-FITC)/(Texas Red-Texas Red))6100. A
minimum of 6 fields containing an average of 10 cells were
analyzed per treatment. The data were compiled from at least 3
independent experiments and were normalized to no drug
treatment samples and are presented as means6standard error.
Transfection studies
HeLa, NIH 3T3, or Abl/Arg2/2 cells were seeded on 12 mm
glass coverslips in 6 well plates and transfected with the indicated
plasmid constructs using Effectene (Invitrogen) following manu-
facturer’s instructions. Expression from the EGFP and EGFP-
TARP constructs were allowed to proceed for 24 hours at 37uC as
previously described [16] and expression from the all Abl kinase
constructs was allowed to proceed for 48 hours as previously
described [55] before infecting with C. trachomatis. Coverslips from
transfected cells were processed for immunofluorescence as
described above. Actin staining was performed using fluoro-
phore-conjugated phalloidin (Molecular Probes) for 2 hours. The
remaining cells were harvested and immunoblotted as described
above.
Statistical analysis
Data represented the mean6standard error of n experiments.
Statistical analysis was performed using the software program
Instat. The significance between groups was determined by
ANOVA. A p value less than 0.05 was considered to be statistically
significant.
Accession numbers
The FlyBase (http://flybase.bio.indiana.edu/search/) accession
numbers for the genes and gene products discussed in this paper
are Pvr (FBgn0032006), Abl kinase (FBgn0000017), SCAR/
WAVE (FBgn 0041781), Vav (FBgn 0040068), and Cortactin
(FBgn 0025865). The NCBI Entrez (http://www.ncbi.nlm.nih.
gov/gquery/gquery.fcgi) accession numbers for human genes
discussed in this paper are PDGFRb (NP_002600), PDGF-B
(NP_002599, NP_148937), Abl kinase (NP_005148, NP_009297),
WAVE2 (NP_008921), Vav2 (NP_003362), Cortactin
(NP_612632, NP_005222), EGFR (NP_958441, NP_958439),
and TARP (AY623902).
Supporting Information
Table S1 Genes identified in RNAi screen. Genes were
organized according to phenotypes as observed by immunofluo-
rescence microscopy. Gene function was as described in Flybase,
information hyperlinked over proteins (iHOP), or by gene
homologies. Human gene homology was determined by iHOP.
Found at: doi:10.1371/journal.ppat.1000021.s001 (0.04 MB XLS)
Figure S1 PDGFR is not necessary for activation of Abl kinase
upon C. trachomatis infection or for tyrosine phosphorylation of
proteins associated with EBs. HeLa cells were infected with C.
trachomatis for 1 hr in the absence or presence of STI571 or
AG1295. (A) The percentage of EBs associated with phospho-
Abl were quantified by IF using the phospho-Abl Y412 antibody,
and values are shown as the mean6s.e.m. Data are from two
independent experiments, and approximately 500 EBs were
counted. ***p,0.001 compared with DMSO-treated and
AG1295-treated HeLa cells (ANOVA). (B) The percentage of
EBs associated with tyrosine phosphorylated proteins was
quantified by IF using the 4G10 antibody, and values are shown
as the mean6s.e.m. Data are from two independent experiments,
and approximately 500 EBs were counted. ***p,0.001 compared
with DMSO-treated and AG1295-treated HeLa cells (ANOVA).
Found at: doi:10.1371/journal.ppat.1000021.s002 (1.65 MB TIF)
Figure S2 Abl Kinase is necessary for tyrosine phosphorylation
of proteins associated with EBs. The percentage of EBs
associated with tyrosine phosphorylated proteins was quantified
by IF using the 4G10 antibody in C. trachomatis-infected (A) NIH
3T3 and Abl/Arg2/2 or (B) control and Abl siRNA-treated HeLa
cells treated with DMSO or STI571. Values are shown as the
mean6s.e.m. Data are from at least three independent experi-
ments, and approximately 1000 EBs were counted. ***p,0.001
(ANOVA) compared to DMSO-treated NIH 3T3 (A) or DMSO-
treated control siRNA (B).
Found at: doi:10.1371/journal.ppat.1000021.s003 (1.79 MB TIF)
Figure S3 Abl Kinase is sufficient for tyrosine phosphorylation of
proteins associated with EBs. NIH 3T3 (panels A–H) and Abl/
Arg2/2 cells (panels I–P) were transfected with plasmids encoding
HA-Abl (panels E–H and M–P) or EGFP (panels A–D and I–L) for
48 hours, infected with C. trachomatis for 1 hour, and then stained for
tyrosine phosphorylation using 4G10 (panels A, E, I, and M; red in
merge). Cells expressing HA-Abl were visualized by staining with an
anti-HA antibody (panels F and N; green in merge). Bacteria and
host DNA were detected using DAPI (panels C, G, K, and O; blue
in merge). The exposure time for each filter of all images was
identical. Expression of Abl kinase is sufficient to restore EB-
associated tyrosine phosphorylation in Abl/Arg2/2 cells.
Found at: doi:10.1371/journal.ppat.1000021.s004 (8.40 MB TIF)
Figure S4 Dose-dependent inhibition of Abl kinase activity by
STI571 treatment. HeLa cells were pretreated with DMSO or
the indicated concentration of STI571 for 1 hr and subsequently
infected with C. trachomatis in the presence of DMSO or STI571.
Abl kinase activity was assessed by analyzing the phosphorylation
of CrkII, an Abl kinase substrate. CrkII was immunoprecipitated
from lysates and immunoblotted with anti-phospho-CrkII
(Tyr221) antibody to assess phosphorylation. Blots were reprobed
with total CrkII antibody to determine total protein amounts. All
samples were run on the same gel and exposed the same amount
of time. The percentage of phosphorylated protein compared to
total protein was quantified by densitometry analysis and
normalized relative to C. trachomatis-infected samples. Immuno-
blots shown are representative of three independent experiments.
Abl kinase activity is inhibited with increasing doses of STI571.
Found at: doi:10.1371/journal.ppat.1000021.s005 (2.79 MB TIF)
Figure S5 C. trachomatis -induced phosphorylation of WAVE2,
Vav2, and Cortactin is diminished by STI571. HeLa cells were
treated with DMSO or STI571 for 1 hour, and then subsequently
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infected with C. trachomatis for 1 hour. WAVE2 and Cortactin were
immunoprecipitated from lysates and immunoblotted with 4G10
to assess phosphorylation. Blots were reprobed with the indicated
antibody to determine total protein amounts. Lysates from the
same set of samples were probed with an anti-pVav2 and total
Vav2 antibodies. The percentage of phosphorylated protein
compared to total protein was quantified by densitometry analysis
and normalized relative to C. trachomatis-infected samples.
Immunoblots shown are representative of three independent
experiments. WAVE2, Vav2, and Cortactin phosphorylation is
diminished by STI571.
Found at: doi:10.1371/journal.ppat.1000021.s006 (2.51 MB TIF)
Figure S6 Colocalization of Abl kinase and TARP. HeLa cells
were transfected with a vector encoding EGFP (A–D) or EGFP-
TARP (E–H) for 24 hours. Cells were then fixed and stained with
anti-Abl (B and F; red in merge). Actin was stained with phalloidin
(C and G; blue in merge). The exposure time for each filter of all
images was identical. Note the colocalization of EGFP-TARP and
Abl kinase.
Found at: doi:10.1371/journal.ppat.1000021.s007 (9.24 MB TIF)
Acknowledgments
The dsRNA library used in this study was produced as a collaboration
between Graeme Davis, Ben Eaton, Edan Foley, Patrick O’Farrell, Steve
Rogers, Nico Stuurman, and Ronald Vale at the University of California,
San Francisco (UCSF). The primary screen was performed in conjunction
with Edan Foley, Alexander D. Johnson, Patrick O’Farrell, and Shannon
L. Stroschein-Stevenson. We thank Yuh Nung Jan for dsRNA templates
for secondary screens. Amplification of the library was performed by AC,
CAE, JHK, and Julia Pielage. Finally, we thank members of the Engel lab
for advice and encouragement. We kindly acknowledge the gift of reagents
from Dr. Rey Carabeo (U of L) and Dr. Ronald Vale (UCSF).
Author Contributions
Conceived and designed the experiments: CAE JNE. Performed
the experiments: CAE AC JHK. Analyzed the data: CAE JNE.
Contributed reagents/materials/analysis tools: CAE DK. Wrote the paper:
CAE JNE.
References
1. Schachter J (1988) The intracellular life of Chlamydia. Curr Topics Microbiol
Immunol 138: 109–139.
2. Campbell LA, Kuo CC (2003) Chlamydia pneumoniae and atherosclerosis.
Semin Respir Infect 18: 48–54.
3. Moulder JW (1991) Interaction of chlamydiae and host cells in vitro. Microbiol
Rev 55: 143–190.
4. Hackstadt T (2000) Redirection of host vesicle trafficking pathways by
intracellular parasites. Traffic 1: 93–99.
5. Zhang JP, Stephens RS (1992) Mechanism of Chlamydia trachomatis attachment to
eukaryotic host cells. Cell 69: 861–869.
6. Gutierrez-Martin CB, Ojcius DM, Hsia R, Hellio R, Bavoil PM, et al. (1997)
Heparin-mediated inhibition of Chlamydia psittaci adherence to HeLa cells.
Microb Pathog 22: 47–57.
7. Taraktchoglou M, Pacey AA, Turnbull JE, Eley A (2001) Infectivity of
Chlamydia trachomatis serovar LGV but not E is dependent on host cell
heparan sulfate. Infect Immun 69: 968–976.
8. Wuppermann FN, Hegemann JH, Jantos CA (2001) Heparan sulfate-like
glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae. J Infect Dis
184: 181–187.
9. Carabeo RA, Hackstadt T (2001) Isolation and characterization of a mutant
Chinese hamster ovary cell line that is resistant to Chlamydia trachomatis infection
at a novel step in the attachment process. Infect Immun 69: 5899–5904.
10. Fudyk T, Olinger L, Stephens RS (2002) Selection of mutant cell lines resistant
to infection by Chlamydia trachomatis and Chlamydia pneumoniae. Infect Immun 70:
6444–6447.
11. Carabeo RA, Grieshaber SS, Fischer E, Hackstadt T (2002) Chlamydia
trachomatis induces remodeling of the actin cytoskeleton during attachment and
entry into HeLa cells. Infect Immun 70: 3793–3803.
12. Carabeo RA, Grieshaber SS, Hasenkrug A, Dooley C, Hackstadt T (2004)
Requirement for the Rac GTPase in Chlamydia trachomatis Invasion of Non-
phagocytic Cells. Traffic 5: 418–425.
13. Subtil A, Wyplosz B, Balana ME, Dautry-Varsat A (2004) Analysis of Chlamydia
caviae entry sites and involvement of Cdc42 and Rac activity. J Cell Sci 117:
3923–3933.
14. Birkelund S, Johnsen H, Christiansen G (1994) Chlamydia trachomatis serovar L2
induces protein tyrosine phosphorylation during uptake by HeLa cells. Infect
Immun 62: 4900–4908.
15. Fawaz F, van Ooij C, Mutka S, Engel J (1997) Infection with Chlamydia trachomatis
alters the tyrosine phosphorylation and/or localization of several host proteins
including cortactin. Infect Immun 65: 5301–5308.
16. Clifton DR, Dooley CA, Grieshaber SS, Carabeo RA, Fields KA, et al. (2005)
Tyrosine phosphorylation of the chlamydial effector protein Tarp is
species specific and not required for recruitment of actin. Infect Immun 73:
3860–3868.
17. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, et al. (2004) A
chlamydial type III translocated protein is tyrosine-phosphorylated at the site of
entry and associated with recruitment of actin. Proc Natl Acad Sci U S A 101:
10166–10171.
18. Woodring PJ, Hunter T, Wang JY (2003) Regulation of F-actin-dependent
processes by the Abl family of tyrosine kinases. J Cell Sci 116: 2613–2626.
19. Jewett TJ, Fischer ER, Mead DJ, Hackstadt T (2006) Chlamydial TARP is a
bacterial nucleator of actin. Proc Natl Acad Sci U S A 103: 15599–15604.
20. Liu BP, Burridge K (2000) Vav2 activates Rac1, Cdc42, and RhoA downstream
from growth factor receptors but not beta1 integrins. Mol Cell Biol 20:
7160–7169.
21. Abe K, Rossman KL, Liu B, Ritola KD, Chiang D, et al. (2000) Vav2 is an
activator of Cdc42, Rac1, and RhoA. J Biol Chem 275: 10141–10149.
22. Moores SL, Selfors LM, Fredericks J, Breit T, Fujikawa K, et al. (2000) Vav
family proteins couple to diverse cell surface receptors. Mol Cell Biol 20:
6364–6373.
23. Pandey A, Podtelejnikov AV, Blagoev B, Bustelo XR, Mann M, et al. (2000)
Analysis of receptor signaling pathways by mass spectrometry: identification of
vav-2 as a substrate of the epidermal and platelet-derived growth factor
receptors. Proc Natl Acad Sci U S A 97: 179–184.
24. Stuart JR, Gonzalez FH, Kawai H, Yuan ZM (2006) c-Abl interacts with the
WAVE2 signaling complex to induce membrane ruffling and cell spreading.
J Biol Chem 281: 31290–31297.
25. Leng Y, Zhang J, Badour K, Arpaia E, Freeman S, et al. (2005) Abelson-
interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated
tyrosine phosphorylation required for WAVE2 activation. Proc Natl Acad
Sci U S A 102: 1098–1103.
26. Boyle SN, Michaud GA, Schweitzer B, Predki PF, Koleske AJ (2007) A critical
role for cortactin phosphorylation by Abl-family kinases in PDGF-induced
dorsal-wave formation. Curr Biol 17: 445–451.
27. Elwell C, Engel J (2005) Drosophila melanogaster S2 cells: A Model System to Study
Chlamydia Interaction with Host Cells. Cell Microbiol in press.
28. Foley E, O’Farrell PH (2004) Functional Dissection of an Innate Immune
Response by a Genome-Wide RNAi Screen. PLoS Biol 2: E203.
29. Agaisse H, Burrack LS, Philips JA, Rubin EJ, Perrimon N, et al. (2005) Genome-
wide RNAi screen for host factors required for intracellular bacterial infection.
Science 309: 1248–1251.
30. Stroschein-Stevenson SL, Foley E, O’Farrell PH, Johnson AD (2005)
Identification of Drosophila Gene Products Required for Phagocytosis of
Candidaalbicans. PLoS Biol 4: e4.
31. van Ooij C, van Ijzendoorn S, Nishijima M, Hantada K, Mostov K, et al. (2000)
Host derived sphingolipids are required for the intracellular growth of Chlamydia
trachomatis. Cell Microbiol 2: 627–638.
32. Rzomp KA, Scholtes LD, Briggs BJ, Whittaker GR, Scidmore MA (2003) Rab
GTPases are recruited to chlamydial inclusions in both a species-dependent and
species-independent manner. Infect Immun 71: 5855–5870.
33. Rzomp KA, Moorhead AR, Scidmore MA (2006) The GTPase Rab4 interacts
with Chlamydia trachomatis inclusion membrane protein CT229. Infect Immun
74: 5362–5373.
34. Moorhead AR, Rzomp KA, Scidmore MA (2007) The Rab6 effector Bicaudal
D1 associates with Chlamydia trachomatis inclusions in a biovar-specific
manner. Infect Immun 75: 781–791.
35. Cortes C, Rzomp KA, Tvinnereim A, Scidmore MA, Wizel B (2007) Chlamydia
pneumoniae inclusion membrane protein Cpn0585 interacts with multiple Rab
GTPases. Infect Immun.
36. Feller SM (2001) Crk family adaptors-signalling complex formation and
biological roles. Oncogene 20: 6348–6371.
37. Matsumoto T, Yokote K, Take A, Takemoto M, Asaumi S, et al. (2000)
Differential interaction of CrkII adaptor protein with platelet-derived growth
factor alpha- and beta-receptors is determined by its internal tyrosine
phosphorylation. Biochem Biophys Res Commun 270: 28–33.
38. Heldin CH (1997) Simultaneous induction of stimulatory and inhibitory signals
by PDGF. FEBS Lett 410: 17–21.
39. Druker BJ, Sawyers CL, Capdeville R, Ford JM, Baccarani M, et al. (2001)
Chronic myelogenous leukemia. Hematology Am Soc Hematol Educ Program.
pp 87–112.
Signaling during Chlamydia Entry
PLoS Pathogens | www.plospathogens.org 14 2008 | Volume 4 | Issue 3 | e1000021
40. Buchdunger E, O’Reilly T, Wood J (2002) Pharmacology of imatinib (STI571).
Eur J Cancer 38 Suppl 5: S28–36.
41. Kovalenko M, Gazit A, Bohmer A, Rorsman C, Ronnstrand L, et al. (1994)
Selective platelet-derived growth factor receptor kinase blockers reverse sis-
transformation. Cancer Res 54: 6106–6114.
42. Wang JY (1993) Abl tyrosine kinase in signal transduction and cell-cycle
regulation. Curr Opin Genet Dev 3: 35–43.
43. Pendergast AM (2002) The Abl family kinases: mechanisms of regulation and
signaling. Adv Cancer Res 85: 51–100.
44. Plattner R, Kadlec L, DeMali KA, Kazlauskas A, Pendergast AM (1999) c-Abl is
activated by growth factors and Src family kinases and has a role in the cellular
response to PDGF. Genes Dev 13: 2400–2411.
45. Plattner R, Pendergast AM (2003) Activation and signaling of the Abl tyrosine
kinase: bidirectional link with phosphoinositide signaling. Cell Cycle 2: 273–274.
46. Pluk H, Dorey K, Superti-Furga G (2002) Autoinhibition of c-Abl. Cell 108:
247–259.
47. Dorey K, Engen JR, Kretzschmar J, Wilm M, Neubauer G, et al. (2001)
Phosphorylation and structure-based functional studies reveal a positive and a
negative role for the activation loop of the c-Abl tyrosine kinase. Oncogene 20:
8075–8084.
48. Brasher BB, Van Etten RA (2000) c-Abl has high intrinsic tyrosine kinase activity
that is stimulated by mutation of the Src homology 3 domain and by
autophosphorylation at two distinct regulatory tyrosines. J Biol Chem 275:
35631–35637.
49. Koleske AJ, Gifford AM, Scott ML, Nee M, Bronson RT, et al. (1998) Essential
roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21:
1259–1272.
50. Echarri A, Pendergast AM (2001) Activated c-Abl is degraded by the ubiquitin-
dependent proteasome pathway. Curr Biol 11: 1759–1765.
51. Soubeyran P, Barac A, Szymkiewicz I, Dikic I (2003) Cbl-ArgBP2 complex
mediates ubiquitination and degradation of c-Abl. Biochem J 370: 29–34.
52. Birkelund S, Bini L, Pallini V, Sanchez-Campillo M, Liberatori S, et al. (1997)
Characterization of Chlamydia trachomatis L2-induced tyrosine phosphorylated
HeLa cell proteins by two-dimensional gel electrophoresis. Electrophoresis 18:
563–567.
53. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, et al. (2004) A
Chlamydial type III translocated protein is tyrosine phosphorylated at the site of
entry and associated with recruitment of actin. Proc Natl Acad Sci U S A.
54. Peng B, Lloyd P, Schran H (2005) Clinical pharmacokinetics of imatinib. Clin
Pharmacokinet 44: 879–894.
55. Swimm A, Bommarius B, Li Y, Cheng D, Reeves P, et al. (2004)
Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin
pedestals. Mol Biol Cell 15: 3520–3529.
56. Carabeo RA, Dooley CA, Grieshaber SS, Hackstadt T (2007) Rac interacts with
Abi-1 and WAVE2 to promote an Arp2/3-dependent actin recruitment during
chlamydial invasion. Cell Microbiol.
57. Hornstein I, Alcover A, Katzav S (2004) Vav proteins, masters of the world of
cytoskeleton organization. Cell Signal 16: 1–11.
58. Bassermann F, Jahn T, Miething C, Seipel P, Bai RY, et al. (2002) Association of
Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1
pathway. J Biol Chem 277: 12437–12445.
59. Wu JJ, Afar DE, Phan H, Witte ON, Lam KS (2002) Recognition of multiple
substrate motifs by the c-ABL protein tyrosine kinase. Comb Chem High
Throughput Screen 5: 83–91.
60. Dautry-Varsat A, Subtil A, Hackstadt T (2005) Recent insights into the
mechanisms of Chlamydia entry. Cell Microbiol 7: 1714–1722.
61. Inaba T, Shimano H, Gotoda T, Harada K, Shimada M, et al. (1993)
Expression of platelet-derived growth factor beta receptor on human monocyte-
derived macrophages and effects of platelet-derived growth factor BB dimer on
the cellular function. J Biol Chem 268: 24353–24360.
62. Orth JD, McNiven MA (2006) Get off my back! Rapid receptor internalization
through circular dorsal ruffles. Cancer Res 66: 11094–11096.
63. Carabeo RA, Grieshaber SS, Dooley CA, Hackstadt T (2004) Chlamydia
trachomatis Invasion Activates Rac to Recruit WAVE2, Arp2/3, and Actin.
;American Society of Microbiology Abstracts: D-222.
64. Lustig F, Hoebeke J, Ostergren-Lunden G, Velge-Roussel F, Bondjers G, et al.
(1996) Alternative splicing determines the binding of platelet-derived growth
factor (PDGF-AA) to glycosaminoglycans. Biochemistry 35: 12077–12085.
65. Abramsson A, Kurup S, Busse M, Yamada S, Lindblom P, et al. (2007)
Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding
and pericyte recruitment in vascular development. Genes Dev 21: 316–331.
66. Verbeke P, Welter-Stahl L, Ying S, Hansen J, Hacker G, et al. (2006)
Recruitment of BAD by the Chlamydia trachomatis vacuole correlates with
host-cell survival. PLoS Pathog 2: e45.
67. Yao R, Cooper GM (1995) Requirement for phosphatidylinositol-3 kinase in the
prevention of apoptosis by nerve growth factor. Science 267: 2003–2006.
68. Plattner R, Koleske AJ, Kazlauskas A, Pendergast AM (2004) Bidirectional
Signaling Links the Abelson Kinases to the Platelet-Derived Growth Factor
Receptor. Mol Cell Biol 24: 2573–2583.
69. Plattner R, Irvin BJ, Guo S, Blackburn K, Kazlauskas A, et al. (2003) A new link
between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-
gamma1. Nat Cell Biol 5: 309–319.
70. Veracini L, Franco M, Boureux A, Simon V, Roche S, et al. (2006) Two distinct
pools of Src family tyrosine kinases regulate PDGF-induced DNA synthesis and
actin dorsal ruffles. J Cell Sci 119: 2921–2934.
71. Ting AY, Kain KH, Klemke RL, Tsien RY (2001) Genetically encoded
fluorescent reporters of protein tyrosine kinase activities in living cells. Proc Natl
Acad Sci U S A 98: 15003–15008.
72. Miki H, Suetsugu S, Takenawa T (1998) WAVE, a novel WASP-family protein
involved in actin reorganization induced by Rac. Embo J 17: 6932–6941.
73. Uruno T, Liu J, Zhang P, Fan Y, Egile C, et al. (2001) Activation of Arp2/3
complex-mediated actin polymerization by cortactin. Nat Cell Biol 3: 259–266.
74. Weaver AM, Karginov AV, Kinley AW, Weed SA, Li Y, et al. (2001) Cortactin
promotes and stabilizes Arp2/3-induced actin filament network formation. Curr
Biol 11: 370–374.
75. Selbach M, Backert S (2005) Cortactin: an Achilles’ heel of the actin cytoskeleton
targeted by pathogens. Trends Microbiol 13: 181–189.
76. Hybiske K, Stephens RS (2007) Entry mechanisms of Chlamydia trachomatis
into non-phagocytic cells. Infect Immun.
77. Bromann PA, Korkaya H, Courtneidge SA (2004) The interplay between Src
family kinases and receptor tyrosine kinases. Oncogene 23: 7957–7968.
78. Bommarius B, Maxwell D, Swimm A, Leung S, Corbett A, et al. (2007)
Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and
activates tyrosine kinases required for pedestal formation. Mol Microbiol 63:
1748–1768.
79. Madureira PA, Matos P, Soeiro I, Dixon LK, Simas JP, et al. (2005) Murine
gamma-herpesvirus 68 latency protein M2 binds to Vav signaling proteins and
inhibits B-cell receptor-induced cell cycle arrest and apoptosis in WEHI-231 B
cells. J Biol Chem 280: 37310–37318.
80. Burton EA, Plattner R, Pendergast AM (2003) Abl tyrosine kinases are required
for infection by Shigella flexneri. Embo J 22: 5471–5479.
81. Coyne CB, Bergelson JM (2006) Virus-induced Abl and Fyn kinase signals
permit coxsackievirus entry through epithelial tight junctions. Cell 124:
119–131.
82. Dewar AL, Cambareri AC, Zannettino AC, Miller BL, Doherty KV, et al.
(2005) Macrophage colony-stimulating factor receptor c-fms is a novel target of
imatinib. Blood 105: 3127–3132.
83. Fabian MA, Biggs WH 3rd, Treiber DK, Atteridge CE, Azimioara MD, et al.
(2005) A small molecule-kinase interaction map for clinical kinase inhibitors. Nat
Biotechnol 23: 329–336.
84. Satou A, Hagio Y, Taira T, Iguchi-Ariga SM, Ariga H (2004) Repression of the
c-fms gene in fibroblast cells by c-Myc-MM-1-TIF1beta complex. FEBS Lett
572: 211–215.
85. Muise-Helmericks RC, Rosen N (1995) Identification of a novel repressive
element in the proximal lck promoter. J Biol Chem 270: 27538–27543.
86. Yu JC, Li W, Wang LM, Uren A, Pierce JH, et al. (1995) Differential
requirement of a motif within the carboxyl-terminal domain of alpha-platelet-
derived growth factor (alpha PDGF) receptor for PDGF focus forming activity
chemotaxis, or growth. J Biol Chem 270: 7033–7036.
87. Lin K, Longo NS, Wang X, Hewitt JA, Abraham KM (2000) Lck domains
differentially contribute to pre-T cell receptor (TCR)- and TCR-alpha/beta-
regulated developmental transitions. J Exp Med 191: 703–716.
88. Garrity-Ryan L, Shafikhani S, Balachandran P, Nguyen L, Oza J, et al. (2004)
The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT
contributes to its biological activities. Infect Immun 72: 546–558.
89. van Ooij C, Apodaca G, Engel J (1997) Characterization of the Chlamydia
trachomatis vacuole and its interaction with the host endocytic pathway in HeLa
cells. Infect Immun 65: 758–766.
90. Caldwell HD, Kromhout J, Schachter J (1981) Purification and partial
characterization of the major outer membrane protein of Chlamydia
trachomatis. Infection and Immunity 31: 1161–1176.
91. Ojcius DM, Bravo de Alba Y, Kanellopoulos JM, Hawkins RA, Kelly KA, et al.
(1998) Internalization of Chlamydia by dendritic cells and stimulation of
Chlamydia-specific T cells. J Immunol 160: 1297–1303.
Signaling during Chlamydia Entry
PLoS Pathogens | www.plospathogens.org 15 2008 | Volume 4 | Issue 3 | e1000021
